These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16097189)

  • 1. The preacher who's raising hell with Merck.
    Parloff R
    Fortune; 2005 Aug; 152(3):20. PubMed ID: 16097189
    [No Abstract]   [Full Text] [Related]  

  • 2. What have we learnt from Vioxx?
    Krumholz HM; Ross JS; Presler AH; Egilman DS
    BMJ; 2007 Jan; 334(7585):120-3. PubMed ID: 17235089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The $22 billion gold rush.
    Lenzner R; Maiello M
    Mo Med; 2007; 104(1):9-11. PubMed ID: 17410817
    [No Abstract]   [Full Text] [Related]  

  • 4. Vioxx doctors wooed by Merck are now its foes.
    Tesoriero HW
    Wall St J (East Ed); 2006 Mar; ():B1, B3. PubMed ID: 16578911
    [No Abstract]   [Full Text] [Related]  

  • 5. Merck cleared in personal injury case against Vioxx.
    Mayor S
    BMJ; 2005 Nov; 331(7525):1101. PubMed ID: 16282390
    [No Abstract]   [Full Text] [Related]  

  • 6. 94% of patients suing Merck over rofecoxib agree to company's offer.
    Charatan F
    BMJ; 2008 Mar; 336(7644):580-1. PubMed ID: 18340064
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug lawsuits building. Merck, Pfizer facing charges of misrepresentation.
    Benko LB
    Mod Healthc; 2006 Apr; 36(15):16. PubMed ID: 16669517
    [No Abstract]   [Full Text] [Related]  

  • 8. The Vioxx pharmaceutical scandal: Peterson v Merke Sharpe & Dohme (Aust) Pty Ltd (2010) 184 FCR 1.
    Faunce T; Townsend R; McEwan A
    J Law Med; 2010 Sep; 18(1):38-49. PubMed ID: 20977160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Painkiller verdict shows mistrust of Merck.
    Khamsi R
    Nature; 2005 Aug; 436(7054):1070. PubMed ID: 16121136
    [No Abstract]   [Full Text] [Related]  

  • 10. Will Merck survive Vioxx?
    Simons J; Stipp D
    Fortune; 2004 Nov; 150(9):90-2, 94, 96-7 passim. PubMed ID: 15543824
    [No Abstract]   [Full Text] [Related]  

  • 11. Despite warnings, drug giant took long path to Vioxx recall.
    Berenson A; Harris G; Meier B; Pollack A
    N Y Times Web; 2004 Nov; ():A1, A32. PubMed ID: 15599982
    [No Abstract]   [Full Text] [Related]  

  • 12. Merck accused of disguising its role in research.
    Cressey D
    Nature; 2008 Apr; 452(7189):791. PubMed ID: 18431823
    [No Abstract]   [Full Text] [Related]  

  • 13. Health Canada lukewarm on Vioxx panel findings.
    Murray S
    CMAJ; 2005 Aug; 173(4):350. PubMed ID: 16103502
    [No Abstract]   [Full Text] [Related]  

  • 14. Merck to pay $5bn in rofecoxib claims.
    Charatan F
    BMJ; 2007 Nov; 335(7628):1011. PubMed ID: 18006982
    [No Abstract]   [Full Text] [Related]  

  • 15. A message from the Vioxx case.
    Baldwin HJ; Droege M; Daniel KL
    Am J Health Syst Pharm; 2006 Mar; 63(6):503. PubMed ID: 16522877
    [No Abstract]   [Full Text] [Related]  

  • 16. NEJM editor gives pretrial evidence in Vioxx case.
    Tanne JH
    BMJ; 2006 Feb; 332(7536):255. PubMed ID: 16455704
    [No Abstract]   [Full Text] [Related]  

  • 17. How Vioxx is changing US drug regulation.
    Zwillich T
    Lancet; 2005 Nov; 366(9499):1763-4. PubMed ID: 16302300
    [No Abstract]   [Full Text] [Related]  

  • 18. Court awards claimant 13.5m dollars in rofecoxib lawsuit.
    Tanne JH
    BMJ; 2006 Apr; 332(7547):927. PubMed ID: 16627492
    [No Abstract]   [Full Text] [Related]  

  • 19. Painkiller in the dock.
    Nature; 2005 Jul; 436(7050):459. PubMed ID: 16049447
    [No Abstract]   [Full Text] [Related]  

  • 20. Vioxx award good news for Canadian lawsuits.
    Eggertson L
    CMAJ; 2005 Sep; 173(7):744. PubMed ID: 16186576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.